FDA Approved: ZINPLAVA — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved a supplemental application for ZINPLAVA (bezlotoxumab) from Merck Sharp & Dohme LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Zinplava (bezlotoxumab)

Snippet

SUPPL AP for ZINPLAVA (BEZLOTOXUMAB)